TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04738175

Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.
“A different study will be conducted.”

The sponsor’s own words in the registry.

Life of this trial

202120222023Registered2021-02-02Planned start2021-04 (planned)Withdrawn (as of)2022-02-25

Vital statistics

Status
Withdrawn
Phase
Phase 1, Phase 2
Sponsor
Sorrento Therapeutics, Inc.
Sponsor type
Industry
Conditions
Covid19
Interventions
COVI-AMG; Placebo
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.